Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ronald W Smith

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Physical Therapy|November 22, 2008
Nonsurgical management of posterior tibial tendon dysfunction with orthoses and resistive exercise: a randomized controlled trialKornelia Kulig, Stephen F Reischl, Amy B Pomrantz, et al.
BMC Musculoskeletal Disorders|June 8, 2006
Non-operative management of posterior tibialis tendon dysfunction: design of a randomized clinical trial [NCT00279630]Kornelia Kulig, Amy B Pomrantz, Judith M Burnfield, et al.
Assay and Drug Development Technologies|April 20, 2004
A high throughput screening assay to screen for CYP2E1 metabolism and inhibition using a fluorogenic vivid p450 substrateBryan D Marks, Ronald W Smith, Heidi A Braun, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Physical Therapy|November 22, 2008
Nonsurgical management of posterior tibial tendon dysfunction with orthoses and resistive exercise: a randomized controlled trialKornelia Kulig, Stephen F Reischl, Amy B Pomrantz, et al.
BMC Musculoskeletal Disorders|June 8, 2006
Non-operative management of posterior tibialis tendon dysfunction: design of a randomized clinical trial [NCT00279630]Kornelia Kulig, Amy B Pomrantz, Judith M Burnfield, et al.
Assay and Drug Development Technologies|April 20, 2004
A high throughput screening assay to screen for CYP2E1 metabolism and inhibition using a fluorogenic vivid p450 substrateBryan D Marks, Ronald W Smith, Heidi A Braun, et al.
Pageof 2